Sierra Leone Secures $129m U.S. Health Partnership

By Mackie M. Jalloh

Sierra Leone and the United States have signed a far-reaching five-year health cooperation agreement valued at more than $129 million, marking one of the most significant bilateral health partnerships the country has entered into in recent years. The agreement, which will run from 2026 to 2030, is designed to confront persistent infectious diseases, strengthen health systems, and improve health outcomes across the country.

The Memorandum of Understanding (MOU) was formally signed in Freetown on Monday by Sierra Leone’s Minister of Health and the U.S. Chargé d’Affaires, underscoring Washington’s renewed commitment to supporting Sierra Leone’s public health agenda. With this deal, Sierra Leone joins a small group of African countries that have secured such a comprehensive, long-term health cooperation framework with the U.S. government.

At the core of the agreement are ambitious and clearly defined targets aimed at reversing some of the country’s most stubborn health challenges. Over the next half-decade, the partnership seeks to significantly reduce maternal and child mortality, while cutting deaths linked to HIV, tuberculosis, malaria, and measles. These diseases continue to place a heavy burden on Sierra Leone’s fragile health system, particularly in rural and underserved communities.

One of the agreement’s headline goals is to achieve near-universal HIV testing and treatment, a critical step in controlling transmission and improving life expectancy. The MOU also prioritizes health security, with a strong focus on improving Sierra Leone’s capacity to detect, investigate, and respond to disease outbreaks within seven days, a benchmark aligned with global health security standards.

Speaking at the signing ceremony, the Minister of Health described the agreement as a turning point for the country’s health sector. He emphasized that the partnership goes beyond financial support and is rooted in shared responsibility and measurable outcomes.

“This agreement reflects Sierra Leone’s strong leadership and commitment to building a resilient and self-reliant health system,” the minister said. “It is not just about funding. It is about alignment, accompaniment, acceleration, and accountability, ensuring that real and lasting results are delivered for the people of Sierra Leone.”

The $129 million U.S. contribution will complement increased domestic health financing by the Government of Sierra Leone, signaling a shift toward greater national ownership of health sector reforms. In recent years, the government has taken steps to strengthen the system from within, including placing thousands of frontline health workers on the national payroll, improving supply chain efficiency through reforms at the National Medical Supplies Agency, and expanding digital disease surveillance and health information systems.

U.S. officials noted that the agreement is structured to support primary health care, which remains the backbone of effective and equitable service delivery. By strengthening community-level services, the partnership aims to ensure early detection of illness, continuity of care, and better health outcomes for women, children, and vulnerable populations.

To ensure transparency and accountability, the MOU provides for the establishment of a Joint Health Cooperation Steering Committee. This body will be responsible for overseeing implementation, tracking progress against agreed targets, and ensuring that both parties remain aligned on priorities. The framework also explicitly safeguards Sierra Leone’s data sovereignty and regulatory authority, addressing longstanding concerns about external control over national health data and policies.

Officials from both sides highlighted that the agreement builds on more than 50 years of health cooperation between Sierra Leone and the United States. Past collaborations have played key roles in responding to public health emergencies, including the Ebola outbreak, and in strengthening laboratory systems, workforce training, and disease surveillance.

Beyond health outcomes, the partnership is also framed as an investment in human capital and economic development. Healthier populations, officials noted, are more productive, better able to participate in education and employment, and more resilient to shocks, all of which contribute to long-term national stability and growth.

As Sierra Leone continues to recover from years of underinvestment, health crises, and economic strain, the new agreement is being widely viewed as a critical opportunity to reset the country’s health trajectory. If effectively implemented, the $129 million partnership could help transform Sierra Leone’s health system from one largely focused on crisis response to one anchored in prevention, preparedness, and sustainable care.

Leave a Comment

Your email address will not be published. Required fields are marked *